Institutional Ownership Regeneron Pharmaceuticals, Inc. (REGN)
This table provides information about the institutional ownership of Regeneron Pharmaceuticals, Inc. (REGN). We have compiled data on the 1,526 institutions that hold shares in the stock, with a total of 82.7 Million shares, which have been reported (via 13F filing form) to have a value of $57.3 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
9,320,290
shares
|
$6.46 Billion
0.18% of portfolio
|
Q3 2024
Added 3.63%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
8,446,366
shares
|
$5.86 Billion
0.2% of portfolio
|
Q2 2024
Reduced 1.43%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Dec 26, 2024 Q3 2024 |
7,489,500
shares
|
$5.19 Billion
0.64% of portfolio
|
Q3 2024
Reduced 9.52%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
4,902,404
shares
|
$3.4 Billion
0.21% of portfolio
|
Q3 2024
Added 1.27%
|
|
|
Capital World Investors
Los Angeles, CA |
Nov 13, 2024 Q3 2024 |
4,298,387
shares
|
$2.98 Billion
0.72% of portfolio
|
Q3 2024
Reduced 7.34%
|
|
|
Capital International Investors
Los Angeles, CA |
Nov 13, 2024 Q3 2024 |
3,346,395
shares
|
$2.32 Billion
0.7% of portfolio
|
Q3 2024
Added 6.77%
|
|
|
Dodge & Cox
San Francisco, CA |
Nov 13, 2024 Q3 2024 |
2,311,935
shares
|
$1.6 Billion
1.47% of portfolio
|
Q3 2024
Reduced 0.16%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
2,272,261
shares
|
$1.58 Billion
0.2% of portfolio
|
Q3 2024
Reduced 5.92%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 27, 2024 Q3 2024 |
1,896,086
shares
|
$1.31 Billion
0.6% of portfolio
|
Q3 2024
Reduced 15.31%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
1,275,303
shares
|
$884 Million
0.15% of portfolio
|
Q3 2024
Added 36.71%
|
|
|
Putnam Investments LLC
Boston, MA |
Feb 14, 2024 Q4 2023 |
1,210,735
shares
|
$839 Million
1.46% of portfolio
|
Q4 2023
Added 2.05%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
1,185,488
shares
|
$822 Million
0.09% of portfolio
|
Q3 2024
Reduced 11.62%
|
|
|
Loomis Sayles & CO L P
|
Nov 13, 2024 Q3 2024 |
1,181,352
shares
|
$819 Million
1.63% of portfolio
|
Q3 2024
Reduced 2.92%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 12, 2024 Q3 2024 |
1,161,173
shares
|
$805 Million
0.24% of portfolio
|
Q3 2024
Added 26.71%
|
|
|
Amundi
Paris, I0 |
Nov 13, 2024 Q3 2024 |
1,064,246
shares
|
$738 Million
0.42% of portfolio
|
Q3 2024
Reduced 0.01%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
993,237
shares
|
$689 Million
0.09% of portfolio
|
Q3 2024
Added 2.6%
|
|
|
Legal & General Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
959,127
shares
|
$665 Million
0.21% of portfolio
|
Q3 2024
Reduced 1.94%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
918,645
shares
|
$637 Million
0.16% of portfolio
|
Q3 2024
Reduced 4.97%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
755,112
shares
|
$523 Million
0.21% of portfolio
|
Q3 2024
Reduced 10.92%
|
|
|
American Century Companies Inc
Kansas City, MO |
Nov 12, 2024 Q3 2024 |
738,495
shares
|
$512 Million
0.46% of portfolio
|
Q3 2024
Reduced 10.58%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
686,639
shares
|
$476 Million
0.21% of portfolio
|
Q3 2024
Added 14.0%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
673,261
shares
|
$467 Million
0.14% of portfolio
|
Q3 2024
Added 1.74%
|
|
|
Capital Research Global Investors
Los Angeles, CA |
Nov 13, 2024 Q3 2024 |
644,868
shares
|
$447 Million
0.15% of portfolio
|
Q3 2024
Added 15.4%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
609,043
shares
|
$422 Million
0.11% of portfolio
|
Q3 2024
Reduced 11.55%
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2024 Q3 2024 |
579,518
shares
|
$402 Million
0.21% of portfolio
|
Q3 2024
Reduced 16.63%
|